Bio-Rad Laboratories (BIO)
$362.69
0.00 (0.00%)
18:30 EST
BIO Stock Quote Delayed 15 Minutes
Previous Close
$362.69
Market Cap
8.96B
PE Ratio
14.26
EPS
25.43
Volume (Avg. Vol.)
Day's Range
362.69 - 362.69
52-Week Range
220.05 - 376.43
Dividend & Yield
N/A (N/A)
BIO Stock Predictions, Articles, and Bio-Rad Laboratories News
- From InvestorPlace
- From the Web
5 Stocks to Buy in the Mighty Middle
If you're looking for real long term growth, then mid-cap stocks have to be on your menu. Here are 5 that are some of the best examples of what the market segment has to offer.
Outstanding Measures for Earnings Momentum Keep Bio Rad Laboratories (BIO) a Strong Buy
Currently, Bio Rad Laboratories Inc (NYSE:BIO) has a Strong Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. BIO has maintained this ranking for the last month.
Best-in-Class Metrics for Earnings Growth Keep Bio Rad Laboratories (BIO) a Strong Buy
Bio Rad Laboratories Inc (NYSE:BIO) is ranked as a Strong Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. BIO has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy.
Bio Rad Laboratories (BIO) a Strong Buy on High-Level Quant Score
With a $7.6 billion market value, Bio Rad Laboratories Inc (NYSE:BIO) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top quarter of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader score places it 1 among the 32 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 10 among the 781 companies in the sector, and number 69 in the nearly 5,000 company Portfolio Grader universe.
Quant Score Metrics Drive Bio Rad Laboratories (BIO) to Strong Buy
Bio Rad Laboratories Inc (NYSE:BIO) is one of 33 companies within the Life Sciences Tools & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. BIO has a market value of $7.7 billion which is in the top 25% of its industry group. The stock's current Portfolio Grader score places it 1 among the 33 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 10 among the 782 companies in the sector, and number 69 in the nearly 5,000 company Portfolio Grader universe.
Rating on Bio Rad Laboratories (BIO) Raised to Strong Buy From a Buy
Currently, Bio Rad Laboratories Inc (NYSE:BIO) has a Strong Buy using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. BIO has been upgraded from a Buy to a Strong Buy in the last week.
Quant Score Makes Bio Rad Laboratories (BIO) a Buy
Currently, Bio Rad Laboratories Inc (NYSE:BIO) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 2 months.
Bio Rad Laboratories (BIO) a Buy on Solid Quant Score
Bio Rad Laboratories Inc (NYSE:BIO) ranks in the top half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, with a market value of $6.6 billion. From an investment attractiveness viewpoint, BIO is ranked in the top quartile of the sector with a ranking of 99 among the 782 companies in the sector; the ranking for BIO by Portfolio Grader places it 9 among the 33 companies in this industry group, putting it in the second quartile and number 756 in the 5000 company Portfolio Grader company universe.
Bio Rad Laboratories (BIO) a Buy on Strong Quant Score
The current recommendation of Buy for Bio Rad Laboratories Inc (NYSE:BIO) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. This represents no change from the previous week and is the same ranking BIO has had from Portfolio Grader for 2 months.
Analysts Affirm Bio Rad Laboratories (BIO) Buy Rating
Bio Rad Laboratories Inc (NYSE:BIO) is ranked as a Buy using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BIO has had from Portfolio Grader for the last month.
Analysts Affirm Bio Rad Laboratories (BIO) Buy Rating
Bio Rad Laboratories Inc (NYSE:BIO) is ranked as a Buy using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BIO has had from Portfolio Grader for the last month.
7 Life Sciences Tools & Services Stocks to Buy Now
7 Life Sciences Tools & Services stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
4 Life Sciences Tools & Services Stocks to Sell Now
The ratings of 4 Life Sciences Tools & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Technology Stocks Now – ENS BITA MRVL MU
Technology stocks rose 0.2% on Wall Street on Tuesday.
Hottest Technology Stocks Now – AZZ GLW JBL IM
Technology stocks declined broadly on Wall Street today, with the sector seeing an overall decline of 0.4%.
Hottest Technology Stocks Now – DWRE BDC ENR KYO
Technology stocks rose broadly on Wall Street today, with the sector seeing an overall increase of 0.4%.
Hottest Technology Stocks Now – PRLB MMI BIO BHE
Technology stocks finished down broadly on Wall Street on Wednesday, with the sector seeing an overall decline of 1.3%.
Hottest Technology Stocks Now – SLH AZPN VNET AUO
Technology stocks fell broadly on Wall Street on Monday morning, with the sector seeing an overall decline of 0.4%.
Hottest Technology Stocks Now – HRS NJ MMI RHT
Technology stocks declined broadly on Wall Street today, with the sector seeing an overall decline of 0.4%.
Biggest Movers in Technology Stocks Now – ENR TSM IM ALR
Technology stocks advanced 0.1% on Wall Street so far on Thursday.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
Buy